WuXi AppTec

@WuXi_AppTec

WuXi AppTec provides a broad portfolio of R&D and manufacturing services to advance discoveries and deliver groundbreaking treatments to patients.

US & China
Vrijeme pridruživanja: siječanj 2014.

Tweetovi

Blokirali ste korisnika/cu @WuXi_AppTec

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @WuXi_AppTec

  1. Prikvačeni tweet
    3. sij

    This year we’re hosting , medicine & healthcare leaders striving for transformative solutions for patients. We are thrilled that will be hosting us this January 14th for our at . Our full agenda:

    Poništi
  2. prije 12 sati

    approval for Nubeqa®. Read more about this for :

    Poništi
  3. 1. velj

    “Initial data show encouraging clinical activity with manageable safety profile” Read more:

    Poništi
  4. 1. velj

    Breakthrough Therapy Designation syndromes Read more:

    Poništi
  5. 1. velj

    A producing exciting positive top-line results. Read more:

    Poništi
  6. 31. sij

    “Initial data show encouraging clinical activity with manageable safety profile” Read more:

    Poništi
  7. 31. sij

    Breakthrough Therapy Designation syndromes. Read more:

    Poništi
  8. 31. sij

    A producing exciting positive top-line results. Read more:

    Poništi
  9. 30. sij

    Announcing the postponement of the WuXi Healthcare Forum 2020. We are closely monitoring the coronavirus outbreak, and will provide an update regarding new dates for the Forum in the near future. We thank you for your support and understanding.

    Poništi
  10. 30. sij
    Poništi
  11. 30. sij
    Poništi
  12. 30. sij

    Priority Review for New Drug Application

    Poništi
  13. 30. sij

    Exciting positive topline phase 2 study results! :

    Poništi
  14. 29. sij

    "In all patients KRAS levels decreased to undetectable in the 1st cycle of onvansertib treatment.” Read more:

    Poništi
  15. 29. sij
    Poništi
  16. 22. sij

    Congratulations to Chi-Med for achieving their Primary Endpoint early.

    Poništi
  17. 22. sij

    “Revolution Medicines is trying to drug the undruggable with small molecules that block the signaling pathways these proteins use to help cancer grow and thrive.” Read more:

    Poništi
  18. 15. sij

    Thank you to Steve Bates, CEO of for his great concluding remarks! Now we invite all of our speakers and attendees to our reception!

    Poništi
  19. 15. sij

    The second part of the final session of the has completed! How is Technology Shaping the Future of Healthcare? In a big way!

    Poništi
  20. proslijedio/la je Tweet
    14. sij

    Welcoming everyone to the at is chairman Dr. Ge Li who said his motivation is to ensure that patients achieve the same life expectancy as healthy individuals. We are very proud to be partners with WuXi.

    Poništi
  21. 15. sij

    Hans Bishop, CEO of GRAIL, left the audience with an inspiring message for all of us striving towards for patients. He said, “There is nothing better then focusing on really hard important problems.” We agree! Thank you to for moderating.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·